AlzChem Group AG (FRA:ACT)
Germany
· Delayed Price · Currency is EUR 151.40
+3.40 (2.30%)
Last updated: Aug 14, 2025
AlzChem Group AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 555.54 | 554.23 | 540.65 | 542.22 | 422.29 | 379.26 | Upgrade
|
| Other Revenue | 10.72 | 9.21 | 5.14 | 7.31 | 7.11 | 6.82 | Upgrade
|
| Revenue | 566.25 | 563.44 | 545.79 | 549.53 | 429.41 | 386.07 | Upgrade
|
| Revenue Growth (YoY) | 2.69% | 3.23% | -0.68% | 27.97% | 11.22% | 0.27% | Upgrade
|
| Cost of Revenue | 207.72 | 214.97 | 241.72 | 279.26 | 171.1 | 145.69 | Upgrade
|
| Gross Profit | 358.53 | 348.47 | 304.07 | 270.27 | 258.3 | 240.39 | Upgrade
|
| Selling, General & Admin | 167.71 | 164.29 | 149.35 | 138.68 | 133.03 | 128.89 | Upgrade
|
| Other Operating Expenses | 82.25 | 82.92 | 75 | 76.87 | 63.97 | 57.09 | Upgrade
|
| Operating Expenses | 276.28 | 273.52 | 250.26 | 241.09 | 221.47 | 209.08 | Upgrade
|
| Operating Income | 82.25 | 74.95 | 53.81 | 29.17 | 36.84 | 31.31 | Upgrade
|
| Interest Expense | -1.97 | -2.66 | -4.36 | -1.64 | -1 | -2.63 | Upgrade
|
| Interest & Investment Income | 2.57 | 2.21 | 0.35 | 8.21 | 0.63 | 0.19 | Upgrade
|
| Currency Exchange Gain (Loss) | -2.39 | 0.82 | -1.64 | 0.1 | 0.03 | -1.81 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | 5.23 | - | - | Upgrade
|
| EBT Excluding Unusual Items | 80.47 | 75.32 | 48.16 | 41.08 | 36.5 | 27.06 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.02 | 0.02 | 0.03 | 0.21 | 0.02 | 0.13 | Upgrade
|
| Pretax Income | 80.49 | 75.34 | 48.19 | 41.28 | 36.51 | 27.2 | Upgrade
|
| Income Tax Expense | 22.4 | 21.1 | 13.4 | 11.06 | 8.75 | 7.33 | Upgrade
|
| Earnings From Continuing Operations | 58.09 | 54.25 | 34.79 | 30.22 | 27.76 | 19.87 | Upgrade
|
| Minority Interest in Earnings | -0.17 | -0.17 | -0.17 | -0.17 | -0.17 | -0.17 | Upgrade
|
| Net Income | 57.92 | 54.08 | 34.62 | 30.05 | 27.59 | 19.69 | Upgrade
|
| Net Income to Common | 57.92 | 54.08 | 34.62 | 30.05 | 27.59 | 19.69 | Upgrade
|
| Net Income Growth | 25.01% | 56.19% | 15.20% | 8.91% | 40.11% | 9.56% | Upgrade
|
| Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | 10 | Upgrade
|
| Shares Change (YoY) | -0.29% | 0.05% | 0.33% | -0.11% | -0.29% | - | Upgrade
|
| EPS (Basic) | 5.71 | 5.31 | 3.40 | 2.96 | 2.72 | 1.94 | Upgrade
|
| EPS (Diluted) | 5.71 | 5.31 | 3.40 | 2.96 | 2.72 | 1.94 | Upgrade
|
| EPS Growth | 25.37% | 56.12% | 14.82% | 9.03% | 40.52% | 9.56% | Upgrade
|
| Free Cash Flow | 41.36 | 62.05 | 52.11 | -33.31 | 14.48 | 19.88 | Upgrade
|
| Free Cash Flow Per Share | 4.08 | 6.10 | 5.13 | -3.29 | 1.43 | 1.95 | Upgrade
|
| Dividend Per Share | 1.800 | 1.800 | 1.200 | 1.050 | 1.000 | 0.770 | Upgrade
|
| Dividend Growth | 50.00% | 50.00% | 14.29% | 5.00% | 29.87% | 2.67% | Upgrade
|
| Gross Margin | 63.32% | 61.85% | 55.71% | 49.18% | 60.15% | 62.27% | Upgrade
|
| Operating Margin | 14.53% | 13.30% | 9.86% | 5.31% | 8.58% | 8.11% | Upgrade
|
| Profit Margin | 10.23% | 9.60% | 6.34% | 5.47% | 6.43% | 5.10% | Upgrade
|
| Free Cash Flow Margin | 7.30% | 11.01% | 9.55% | -6.06% | 3.37% | 5.15% | Upgrade
|
| EBITDA | 105.74 | 98.44 | 77.08 | 51.96 | 58.66 | 51.97 | Upgrade
|
| EBITDA Margin | 18.67% | 17.47% | 14.12% | 9.46% | 13.66% | 13.46% | Upgrade
|
| D&A For EBITDA | 23.49 | 23.49 | 23.26 | 22.79 | 21.83 | 20.66 | Upgrade
|
| EBIT | 82.25 | 74.95 | 53.81 | 29.17 | 36.84 | 31.31 | Upgrade
|
| EBIT Margin | 14.53% | 13.30% | 9.86% | 5.31% | 8.58% | 8.11% | Upgrade
|
| Effective Tax Rate | 27.82% | 28.00% | 27.80% | 26.79% | 23.96% | 26.96% | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.